MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market
GAITHERSBURG, Md., July 26, 2021 /PRNewswire/ — MaxCyte, Inc., (LSE: MXCT) (LSE: MXCN), a leading provider of platform technologies for cell engineering, today announced the commencement of an underwritten offering of 12,000,000 shares of common stock (the “Offering”) at an expected…
Comments Off on MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market